Difference between revisions of "Drug shortages"
Jump to navigation
Jump to search
m |
m (→ASCO) |
||
| Line 3: | Line 3: | ||
=Guidelines= | =Guidelines= | ||
==ASCO== | ==ASCO== | ||
| + | *'''2023:''' Hantel et al. [https://doi.org/10.1200/jco.23.01941 ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages] [https://pubmed.ncbi.nlm.nih.gov/38061010/ PubMed] | ||
*'''2023:''' Santos et al. [https://doi.org/10.1200/op.23.00545 Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments] [https://pubmed.ncbi.nlm.nih.gov/37963306/ PubMed] | *'''2023:''' Santos et al. [https://doi.org/10.1200/op.23.00545 Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments] [https://pubmed.ncbi.nlm.nih.gov/37963306/ PubMed] | ||
Revision as of 16:14, 25 January 2024
This page will contain useful links regarding the oncology drug shortage crisis from 2023 onwards. For our more general page on therapeutic equivalents, click this link.
Guidelines
ASCO
- 2023: Hantel et al. ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages PubMed
- 2023: Santos et al. Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments PubMed
Anti-Cancer Drugs
Cisplatin
- 2023-06-15: NPR news article
Carboplatin
- 2023-06-15: NPR news article